Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shraddha Bhutkar"'
Autor:
Kimberly Liao, Anthony J. Pellicano, Kai Jiang, Natalia Prakash, Jingsong Li, Shraddha Bhutkar, Zhijian Hu, Quaisar Ali, Itzhak D. Goldberg, Prakash Narayan
Publikováno v:
ACS Omega, Vol 5, Iss 29, Pp 18465-18471 (2020)
Externí odkaz:
https://doaj.org/article/52b1b1d4c13143209000bd74d1b54305
Autor:
Tyler L. Bissoondial, Yiguang Han, Stephanie Mullan, Amrit K. Pabla, Kiera Spahn, Steven Shi, Lana Zheng, Ping Zhou, Kai Jiang, Natalia Prakash, Shraddha Bhutkar, Quaisar Ali, Jingsong Li, Zhijian Hu, Anthony J. Pellicano, Itzhak D. Goldberg, Prakash Narayan
Publikováno v:
Diagnostics, Vol 10, Iss 10, p 784 (2020)
There is increasing evidence that nonalcoholic steatohepatitis (NASH) is a risk factor for hepatocellular carcinoma (HCC) in the absence of cirrhosis, a phenomenon termed noncirrhotic HCC. Early diagnosis of HCC is critical to a favorable prognosis.
Externí odkaz:
https://doaj.org/article/135af65593844de493e4173d5d75c0ff
Autor:
Anjali Yadav, Ali Alnakhli, Hari Priya Vemana, Shraddha Bhutkar, Aaron Muth, Vikas V. Dukhande
Publikováno v:
Pharm Res
PURPOSE: Glioblastoma multiforme (GBM) is a grade IV, highly proliferative, and malignant form of brain tumor with a 5-year survival rate at ~ 5%. Current treatment strategies for GBM include surgery, radiation, and chemotherapy. Major challenges in
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology.
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology.
Autor:
Shrikant Barot, Olivia J. Stephenson, Hari Priya Vemana, Anjali Yadav, Shraddha Bhutkar, Louis D. Trombetta, Vikas V. Dukhande
Publikováno v:
Biochem Pharmacol
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. There is an urgent need for new targets to treat HCC due to limited treatment options and drug resistance. Many cancer cells are known to have high amount of glycog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107e75cc3e1aa4cb719e5466623c8402
https://europepmc.org/articles/PMC10039449/
https://europepmc.org/articles/PMC10039449/
Publikováno v:
Nanomedicine. 16:1081-1095
Aim: To develop novel cationic liposomes as a nonviral gene delivery vector for the treatment of rare diseases, such as Lafora disease – a neurodegenerative epilepsy. Materials & methods: DLinDMA and DOTAP liposomes were formulated and characterize
Autor:
Anjali Yadav, Ali Alnakhli, Hari Priya Vemana, Shraddha Bhutkar, Shrikant Barot, Aaron Muth, Vikas Dukhande
Publikováno v:
The FASEB Journal. 36
Publikováno v:
Nanomedicine (Lond)
AIM: To develop novel cationic liposomes as a nonviral gene delivery vector for the treatment of rare diseases, such as Lafora disease – a neurodegenerative epilepsy. MATERIALS & METHODS: DLinDMA and DOTAP liposomes were formulated and characterize
Publikováno v:
The FASEB Journal. 35